Global Menopause Treatment Market, By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel, By Geography .

Description

The global menopause treatment market was valued US$ 15.33 Bn in 2023 and is expected to reach US$ 24.33 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 15.33 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	5.90%	2030/2031 Value Projection:	US$ 24.33 Bn

Figure 1. Global Menopause Treatment Market Share (%), By Region, 2023

Global Menopause Treatment Market - IMG1

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

Global Menopause Treatment Market, By Treatment Type
- Hormone Therapy
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
Global Menopause Treatment Market, By Route of Administration
- Oral
- Topical
- Parenteral
- Vaginal
- Others
Global Menopause Treatment Market, By Form
- Tablets
- Creams
- Patches
- Pessaries
- Injections
- Others
Global Menopause Treatment Market, By Indication
- Perimenopause
- Menopause
- Postmenopause
Global Menopause Treatment Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Stores
- Others
Global Menopause Treatment Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Menopause Treatment Market:
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.

Product Code: CMI6676

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Route of Administration
- Market Snippet, By Form
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- New Product Launches
- Rising Geriatric Population
- Financial Support Through Funding And Investments
Impact Analysis
Key Highlights
Market Trends
PEST Analysis
Regulatory Scenario
Mergers, Acquisitions, and Collaborations
Key Services Offered
Treatment cost Analysis
Identification of Top Market Players
Government Initiatives and Investments
Brand Mapping & Pricing Analysis
Healthcare Spending by Country

4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Menopause Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Estrogen-based Drugs
Progestin-based Drugs
Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
Non-hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Neurokinin 3 (NK3)
Receptor Antagonist
Selective Serotonin
Reuptake Inhibitor (SSRI)
Others
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Menopause Treatment Market, By Route of Administration, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Menopause Treatment Market, By Form, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Pessaries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Menopause Treatment Market, By Indication, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Perimenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Postmenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Menopause Treatment Market, By Distribution Channel, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

10. Global Menopause Treatment Market, By Region, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region/Country, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region/Country, 2020 - 2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
U.S.
Canada
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

11. Competitive Landscape

Company Profile
- Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- SnapNurse
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
Analyst Views

12. Section

References
Research Methodology
About us